Result of AGM

RNS Number : 6736O

Immupharma PLC

29 May 2015

 

FOR IMMEDIATE RELEASE                                                                            29 MAY 2015

ANNUAL GENERAL MEETING: 2015

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed. A summary of proxy votes is shown in the table below. Please also refer to the 'Notice of the 2015 Annual General Meeting' in the Report & Accounts - 31 December 2014 (page 55).

RESOLUTION	FOR + DISCRETION	%	AGAINST	%	WITHHELD
1	37,051,623	91.52	3,432,424	8.48	300
2	40,327,447	99.61	156,900	0.39	0
3	40,327,447	99.61	156,900	0.39	0
4	40,443,946	99.90	40,000	0.10	0
5	40,441,085	99.90	41,800	0.10	1,462
6 (Special Resolution)	40,323,858	99.61	159,762	0.39	727

For further information please see the Group's web site, www.immupharma.org, or contact:

END

For further information please contact:

ImmuPharma plc	+ 44 (0) 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Dr Robert Zimmer, President and Chief Scientific Officer
Lisa Baderoon, Head of Investor Relations	+ 44 (0) 7721 413496
Panmure, Gordon & Co., NOMAD & Broker	[phone]
Hugh Morgan Fred Walsh Duncan Monteith

 

END

 

 

RAGDMGZKMLLGKZM